meta-analysis | Q815382 |
review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1046/J.1365-2893.2001.00307.X |
P698 | PubMed publication ID | 11555193 |
P2093 | author name string | Liu J | |
Lin H | |||
McIntosh H | |||
P2860 | cites work | Bias in meta-analysis detected by a simple, graphical test | Q24685585 |
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials | Q27860735 | ||
Assessing the quality of reports of randomized clinical trials: is blinding necessary? | Q27860973 | ||
Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses | Q29619185 | ||
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? | Q29619328 | ||
Do certain countries produce only positive results? A systematic review of controlled trials | Q33685036 | ||
The discovery of the hepatitis viruses | Q34355647 | ||
Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: in vitro and in vivo studies | Q34586703 | ||
Phyllanthus amarus suppresses hepatitis B virus by interrupting interactions between HBV enhancer I and cellular transcription factors | Q38341535 | ||
Differential inhibition of reverse transcriptase and cellular DNA polymerase-alpha activities by lignans isolated from Chinese herbs, Phyllanthus myrtifolius Moon, and tannins from Lonicera japonica Thunb and Castanopsis hystrix. | Q38531579 | ||
Current therapeutic trends in therapy for chronic viral hepatitis | Q41667359 | ||
Phyllanthus amarus and hepatitis B. | Q43432265 | ||
Failure of Phyllanthus amarus to eradicate hepatitis B surface antigen from symptomless carriers | Q44641575 | ||
Phyllanthus amarus down-regulates hepatitis B virus mRNA transcription and replication | Q45765030 | ||
P433 | issue | 5 | |
P921 | main subject | Hepatitis B virus | Q6844 |
systematic review | Q1504425 | ||
chronic hepatitis B | Q55779876 | ||
chronic hepatitis | Q62019625 | ||
P304 | page(s) | 358-366 | |
P577 | publication date | 2001-09-01 | |
P1433 | published in | Journal of Viral Hepatitis | Q15749962 |
P1476 | title | Genus Phyllanthus for chronic hepatitis B virus infection: a systematic review | |
P478 | volume | 8 |
Q35962702 | A Complex Multiherbal Regimen Based on Ayurveda Medicine for the Management of Hepatic Cirrhosis Complicated by Ascites: Nonrandomized, Uncontrolled, Single Group, Open-Label Observational Clinical Study |
Q38737694 | A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies |
Q39345969 | A critical review on hepatoprotective effects of bioactive food components. |
Q34331838 | Adverse effects of herbal medicines: an overview of systematic reviews. |
Q26745650 | Anti-fibro-hepatocarcinogenic Chinese herbal medicines: A mechanistic overview |
Q46916580 | Aqueous extract of Phyllanthus niruri (Euphorbiaceae) enhances the phenotypic and functional maturation of bone marrow-derived dendritic cells and their antigen-presentation function |
Q30661938 | Chinese medicinal herbs for chronic hepatitis B. |
Q34092930 | Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review |
Q26775055 | Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects |
Q44535161 | Double-blinded placebo-controlled study of Phyllanthus urinaris for the treatment of chronic hepatitis B. |
Q35655167 | Effects of oral administration of Phyllanthus amarus leaf extract on the kidneys of adult wistar rats: a histological study |
Q53543525 | HPLC-MS/MS method for the determination of four lignans from Phyllanthus urinaria L. in rat plasma and its application. |
Q36269281 | Herbal medicines for liver diseases |
Q36206699 | Herbal supplements |
Q45413673 | In vitro antiviral activities of Chinese medicinal herbs against duck hepatitis B virus |
Q33869291 | Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells |
Q28314366 | Maturation of the adrenal medulla—IV |
Q24235128 | Phyllanthus species for chronic hepatitis B virus infection |
Q24235338 | Phyllanthus species for chronic hepatitis B virus infection |
Q24197858 | Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection |
Q24234607 | Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection |
Q92347704 | Pressurized hot water extraction of hydrosable tannins from Phyllanthus tenellus Roxb |
Q33823928 | The Anti-hepatitis B Virus Activity of Boehmeria nivea Extract in HBV-viremia SCID Mice |
Q50604050 | The effects of Phyllanthus niruri aqueous extract on the activation of murine lymphocytes and bone marrow-derived macrophages. |
Q38860638 | The pharmacological potential of Phyllanthus niruri |
Q34554574 | The use of selected nutrition supplements and complementary and alternative medicine in liver disease |
Q34570675 | Traditional Chinese medicine causing hepatotoxicity in patients with chronic hepatitis B infection: a 1-year prospective study |
Search more.